On February 25, 2020, Ambassador Liu Xiaoming met with Philip Thomson, President of Global Affairs of GlaxoSmithKline (GSK), at the Chinese Embassy in the UK.
Ambassador Liu thanked GSK for its support and assistance to China in fighting the Covid-19 epidemic and expressed his encouragement and support to GSK’s vaccine research collaboration with the Chinese company. Ambassador Liu said that under the strong leadership of the Chinese government and with the staunch support of the international community, including Britain, China has the confidence, capability, and confidence to win the battle against the epidemic. China will continue strengthening research cooperation on the prevention and control of the Covid-19 epidemic, especially on developing new drugs and vaccine in an open, transparent, and responsible manner, and reviewing and sharing China’s experience in fighting against the epidemic in a timely manner, so as to jointly safeguard the security of global public health.
Thomson expressed GSK’s sympathy to China, saying that the measures taken by the Chinese government in combating the epidemic were rigorous, efficient, timely and effective, and China, as a responsible nation, has contributed greatly to the security of global public health. He hoped that China will win the battle against the epidemic at an early date. GSK is ready to continue strengthening cooperation with Chinese companies, he said, adding that the company is currently cooperating with Clover to develop Covid-19 vaccine, hoping to achieve positive results as soon as possible.